A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of ...

Brentuximab vedotin combined with cyclophosphamide, doxorubicin, and prednisone (CHP) shows promising results as a first-line ...

Neoadjuvant immunotherapy is associated with high rates of event-free survival in patients with resectable melanoma.

Scientists have found a surprising connection between vitamin D and a single gene called SDR42E1.